Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00111150 · ClinicalTrials.gov registry record · Phase 2
Botswana Tenofovir Oral HIV Prophylaxis Trial
A Phase 2 study, sponsored by Centers for Disease Control and Prevention.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1,200
- Enrollment target
NCT00111150: Clinical Trial Phase 2 study, sponsored by Centers for Disease Control and Prevention.
NCT00111150 is a Phase 2 study that was terminated before completion, run by Centers for Disease Control and Prevention. The registered enrollment target is 1,200 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (802% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00111150, a Phase 2 study, was terminated before completion, sponsored by Centers for Disease Control and Prevention.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1,200 participants
- Enrollment target
Study Summary
This study will test whether taking a pill of tenofovir (an antiretroviral medicine) is safe for sexually-active young adults in Botswana without HIV infection and whether it will reduce their risk of getting an HIV infection.
Interventions
- DRUG Tenofovir Disoproxil Fumarate 300 mg daily
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,200 participants |
| Start Date | 2005-09 |
| Est. Completion | 2007-03 |
| Phase | Phase 2 |
Why NCT00111150 stopped before completion
NCT00111150 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (802% higher).
The record links to 0 conditions, and to 1 intervention - of which Tenofovir Disoproxil Fumarate 300 mg daily is the first listed.
NCT00111150 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00111150 about?
NCT00111150 is a clinical study titled "Botswana Tenofovir Oral HIV Prophylaxis Trial". This study will test whether taking a pill of tenofovir (an antiretroviral medicine) is safe for sexually-active young adults in Botswana without HIV infection and whether it will reduce their risk of getting an HIV infection.
What is the current status of trial NCT00111150?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1,200 participants. The study started on 2005-09. Estimated completion is 2007-03.
What interventions are being tested in trial NCT00111150?
The interventions under investigation include: Tenofovir Disoproxil Fumarate 300 mg daily (DRUG).
Who is sponsoring clinical trial NCT00111150?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00111150's enrollment target sits among peer trials
1,200 17th of 2000 higher than 1,983 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
- NCT01944332 · 1,200 participants · NA
Gamete Treatment to Correct Fertilization Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia